Immediate Impact
4 from Science/Nature 69 standout
Citing Papers
Pancreatic cancer: Advances and challenges
2023 Standout
NALIRIFOX versus nab-paclitaxel and gemcitabine in treatment-naive patients with metastatic pancreatic ductal adenocarcinoma (NAPOLI 3): a randomised, open-label, phase 3 trial
2023 Standout
Works of P Siegenthaler being referenced
Phase II trial of CPT-11 in patients with advanced pancreatic cancer, an EORTC early clinical trials group study
1995
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| P Siegenthaler | 345 | 272 | 141 | 46 | 692 | |
| Zhaoliang Li | 601 | 133 | 127 | 29 | 836 | |
| Ameen A. Salahudeen | 377 | 98 | 74 | 31 | 749 | |
| Noel R. Monks | 330 | 214 | 40 | 33 | 757 | |
| Dongyu Li | 241 | 66 | 29 | 50 | 651 | |
| R Bossi | 437 | 161 | 45 | 27 | 836 | |
| Tohru Obata | 314 | 180 | 27 | 47 | 737 | |
| Lina Zhao | 373 | 49 | 73 | 36 | 673 | |
| Hee Jong Kim | 440 | 94 | 36 | 40 | 826 | |
| Yusuke Nakamura | 406 | 174 | 35 | 38 | 716 | |
| Suresh Singh Yadav | 480 | 163 | 22 | 43 | 813 |
All Works
Loading papers...